Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial
Wirksamkeit einer personenzentrierten und kultursensitiven Behandlung bei arabisch-, türkisch- und urdusprachigen Menschen mit Typ-2-Diabetes (ACCT2-Studie): Protokoll einer pragmatischen randomisierten kontrollierten Studie
JMIR Research Protocols · 05.06.2025 · 14 · e67319
DOI: 10.2196/67319 ↗Auf einen Blick
Die ACCT2-Studie prüft eine 1-jährige personenzentrierte, kultursensitive Behandlung bei Menschen mit Typ-2-Diabetes. Primärer Endpunkt ist HbA1c.
Fragestellung
Welchen Effekt hat eine 1-jährige personenzentrierte und kultursensitive Intervention auf die glykämische Kontrolle bei arabisch-, türkisch- oder urdusprachigen Menschen mit Typ-2-Diabetes?
Methode
2-armige randomisierte kontrollierte Studie in Dänemark; 96 Erwachsene mit T2D und HbA1c ≥53 mmol/mol; 1:1-Randomisierung zu Intervention oder üblicher Versorgung; Messungen zu Baseline und nach 1 Jahr.
Ergebnisse
Primärer Endpunkt ist HbA1c. Sekundär werden Lipide, Blutdruck sowie patientenberichtete Outcomes, darunter Wohlbefinden, Diabetesmanagement, Gesundheitskompetenz und Medikamentennutzung, erhoben. 88 Teilnehmende waren im Januar 2025 rekrutiert.
Schlussfolgerung der Autor:innen
Die Studie soll Erkenntnisse zu personenzentrierten und kultursensitiven Behandlungsansätzen bei arabisch-, türkisch- oder urdusprachigen Menschen mit T2D liefern. Sie soll auch Einblicke in Erfahrungen, Hindernisse und Umsetzungsstrategien in Ambulanzen geben.
Kernaussagen
- Pragmatische RCT mit 96 Erwachsenen mit T2D
- Primärer Endpunkt: HbA1c nach 1 Jahr
- Sekundär: Wohlbefinden, Diabetesmanagement und Gesundheitskompetenz
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 05.06.2025. Verfasst von Natasja Bjerre und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Education, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark. Hauptthemen laut MEDLINE: Culturally Competent Care, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Individuals with non-Western backgrounds consistently exhibit a higher risk of type 2 diabetes (T2D) than ethnic Danes. Factors such as health behaviors, limited health care access, and social determinants of health often contribute to this disparity. Culturally sensitive interventions are crucial; however, effective interventions for managing T2D in non-Western populations remain limited.
Objective
This study aims to examine the effect of a 1-year person-centered and culturally sensitive intervention on improving glycemic control (hemoglobin A1c [HbA1c]) in Arabic-, Turkish-, or Urdu-speaking individuals with T2D. The secondary objectives are to improve diabetes management and overall well-being.
Methods
This study is designed as a 2-arm randomized controlled trial. A total of 96 women and men with T2D (HbA1c≥53 mmol/mol) speaking either Arabic, Turkish, or Urdu as their native language will be randomized for 1 year to a health care professional–assisted intervention group (person-centered and culturally sensitive course of treatment) or a control group (usual care) in a 1:1 ratio in Denmark. Assessments are scheduled at baseline and 1 year. The primary outcome is HbA1c, while lipids, blood pressure, and patient-reported outcomes, including well-being, diabetes management, health literacy, and use of and adherence to diabetes medication, are secondary outcomes. Feasibility and satisfaction are evaluated through interviews. The study is approved by the Ethics Committee of the Capital Region of Denmark (H-23042245).
Results
A 5.0-mmol/mol change in HbA1c is the minimally important difference, requiring 88 participants. To allow for uncertainties and dropouts, the total was increased to 96. As of January 2025, a total of 88 participants have been recruited. Recruitment was completed in March 2025. Data collection will continue until December 2025, with the first results expected by March 2026.
Conclusions
This study will contribute to the limited knowledge regarding the effects of person-centered and culturally sensitive treatment approaches for T2D in Arabic-, Turkish-, or Urdu-speaking individuals. The study uses a robust methodological design and will present an alternative avenue for managing T2D and improving overall well-being. The study offers valuable insights into the experiences of participants and health care professionals, including potential obstacles and strategies for implementation in outpatient clinics. Trial Registration ClinicalTrials.gov NCT06147245; https://clinicaltrials.gov/study/NCT06147245 International Registered Report Identifier (IRRID) DERR1-10.2196/67319
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Education, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark.
- Centre for Diabetes, Municipality of Copenhagen, Copenhagen, Denmark.
- Department of Diabetes Treatment, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark.
ORCID-Profile: Natasja Bjerre, Lene Christensen, Christina Hoeiberg, Cecilie Ottosson, Mie Klarskov Jensen, Nanna Kildsig, Trine Kjeldgaard Møller, Anne-Ditte Termannsen, Bettina Ewers, Britt Hollender-Schou, Rikke Molin Grue, Ulla Bjerre-Christensen, Solveig Jansen, Kamran Akram
Zitieren
APA
Bjerre, N., Christensen, L., Hoeiberg, C., Ottosson, C., Jensen, M. K., Kildsig, N., Møller, T. K., Termannsen, A. D., Ewers, B., Hollender-Schou, B., Grue, R. M., Bjerre-Christensen, U., Jansen, S., & Akram, K. (2025). Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial. JMIR Research Protocols, 14, e67319. https://doi.org/10.2196/67319
Vancouver
Bjerre N, Christensen L, Hoeiberg C, Ottosson C, Jensen MK, Kildsig N, et al. Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial. JMIR Research Protocols. 2025;14:e67319. doi:10.2196/67319
BibTeX
@article{Bjerre2025,
author = {Bjerre, Natasja and Christensen, Lene and Hoeiberg, Christina and Ottosson, Cecilie and Jensen, Mie Klarskov and Kildsig, Nanna and Møller, Trine Kjeldgaard and Termannsen, Anne-Ditte and Ewers, Bettina and Hollender-Schou, Britt and Grue, Rikke Molin and Bjerre-Christensen, Ulla and Jansen, Solveig and Akram, Kamran},
title = {Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
volume = {14},
pages = {e67319},
doi = {10.2196/67319}
}
EUVIMED